Cita APA

Kinjyo, I., Matlawska-Wasowska, K., Chen, X., Monks, N. R., Burke, P., Winter, S. S., & Wilson, B. S. (2017). Characterization of the anti-CD22 targeted therapy, moxetumomab pasudotox, for B-cell precursor acute lymphoblastic leukemia. Pediatr Blood Cancer.

Chicago Style Citation

Kinjyo, Ichiko, Ksenia Matlawska-Wasowska, Xiaoru Chen, Noel R. Monks, Patricia Burke, Stuart S. Winter, i Bridget S. Wilson. "Characterization of the Anti-CD22 Targeted Therapy, Moxetumomab Pasudotox, for B-cell Precursor Acute Lymphoblastic Leukemia." Pediatr Blood Cancer 2017.

Cita MLA

Kinjyo, Ichiko, et al. "Characterization of the Anti-CD22 Targeted Therapy, Moxetumomab Pasudotox, for B-cell Precursor Acute Lymphoblastic Leukemia." Pediatr Blood Cancer 2017.